Integrating molecular nuclear imaging in clinical research to improve anticancer therapy
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Integrating molecular nuclear imaging in clinical research to improve anticancer therapy
Authors
Keywords
-
Journal
Nature Reviews Clinical Oncology
Volume -, Issue -, Pages -
Publisher
Springer Nature America, Inc
Online
2018-11-27
DOI
10.1038/s41571-018-0123-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Big Data and Machine Learning in Health Care
- (2018) Andrew L. Beam et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- (18)F-fluoroestradiol Tumor Uptake is Heterogeneous and Influenced by Site of Metastasis in Breast Cancer Patients
- (2018) Hilde H. Nienhuis et al. JOURNAL OF NUCLEAR MEDICINE
- Relative Target Affinities of T-Cell–Dependent Bispecific Antibodies Determine Biodistribution in a Solid Tumor Mouse Model
- (2018) Danielle Mandikian et al. MOLECULAR CANCER THERAPEUTICS
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- A PET imaging approach for determining EGFR mutation status for improved lung cancer patient management
- (2018) Xilin Sun et al. Science Translational Medicine
- Bispecific antibodies: design, therapy, perspectives
- (2018) Sergey Sedykh et al. Drug Design Development and Therapy
- Positron Emission Tomography/Computed Tomography–Based Assessments of Androgen Receptor Expression and Glycolytic Activity as a Prognostic Biomarker for Metastatic Castration-Resistant Prostate Cancer
- (2018) Josef J. Fox et al. JAMA Oncology
- Comparative biodistribution analysis across four different 89Zr-monoclonal antibody tracers—The first step towards an imaging warehouse
- (2018) Frederike Bensch et al. Theranostics
- 89Zr-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer
- (2018) Frederike Bensch et al. NATURE MEDICINE
- FDG PET/CT radiomics for predicting the outcome of locally advanced rectal cancer
- (2017) Pierre Lovinfosse et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Intra-image referencing for simplified assessment of HER2-expression in breast cancer metastases using the Affibody molecule ABY-025 with PET and SPECT
- (2017) Dan Sandberg et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Monitoring early response to chemoradiotherapy with 18F-FMISO dynamic PET in head and neck cancer
- (2017) Milan Grkovski et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies
- (2017) Nicolas Aide et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Radiomics to predict immunotherapy-induced pneumonitis: proof of concept
- (2017) Rivka R. Colen et al. INVESTIGATIONAL NEW DRUGS
- Designing Clinical Trials That Accept New Arms: An Example in Metastatic Breast Cancer
- (2017) Steffen Ventz et al. JOURNAL OF CLINICAL ONCOLOGY
- Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
- (2017) Ariadna Tibau et al. JNCI-Journal of the National Cancer Institute
- Future cancer research priorities in the USA: a Lancet Oncology Commission
- (2017) Elizabeth M Jaffee et al. LANCET ONCOLOGY
- iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
- (2017) Lesley Seymour et al. LANCET ONCOLOGY
- The making of bispecific antibodies
- (2017) Ulrich Brinkmann et al. mAbs
- Cancer: Imaging with antibodies
- (2017) Rosie Mestel NATURE
- Elements of cancer immunity and the cancer–immune set point
- (2017) Daniel S. Chen et al. NATURE
- Radiomics: the bridge between medical imaging and personalized medicine
- (2017) Philippe Lambin et al. Nature Reviews Clinical Oncology
- Tumour heterogeneity and resistance to cancer therapies
- (2017) Ibiayi Dagogo-Jack et al. Nature Reviews Clinical Oncology
- Next generation antibody drugs: pursuit of the 'high-hanging fruit'
- (2017) Paul J. Carter et al. NATURE REVIEWS DRUG DISCOVERY
- Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors
- (2017) Jonathan Strosberg et al. NEW ENGLAND JOURNAL OF MEDICINE
- Emerging Use of Early Health Technology Assessment in Medical Product Development: A Scoping Review of the Literature
- (2017) Maarten J. IJzerman et al. PHARMACOECONOMICS
- Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging
- (2017) Steffen Löck et al. RADIOTHERAPY AND ONCOLOGY
- Prognostic value of dynamic hypoxia PET in head and neck cancer: Results from a planned interim analysis of a randomized phase II hypoxia-image guided dose escalation trial
- (2017) Stefan Welz et al. RADIOTHERAPY AND ONCOLOGY
- PD-L1 is an activation-independent marker of brown adipocytes
- (2017) Jessica R. Ingram et al. Nature Communications
- Magnitude of Clinical Benefit of Cancer Drugs Approved by the US Food and Drug Administration
- (2017) Ariadna Tibau et al. JNCI-Journal of the National Cancer Institute
- Multiplexed imaging for diagnosis and therapy
- (2017) Kathrin Heinzmann et al. Nature Biomedical Engineering
- Did the reporting of prognostic studies of tumour markers improve since the introduction of REMARK guideline? A comparison of reporting in published articles
- (2017) Peggy Sekula et al. PLoS One
- Oesophageal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†
- (2016) F. Lordick et al. ANNALS OF ONCOLOGY
- PD-L1 Detection in Tumors Using [64Cu]Atezolizumab with PET
- (2016) Wojciech G. Lesniak et al. BIOCONJUGATE CHEMISTRY
- Selecting a classification function for class prediction with gene expression data
- (2016) Victor L. Jong et al. BIOINFORMATICS
- Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer
- (2016) Maximilian Koch et al. CANCER RESEARCH
- Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study
- (2016) Laetitia E. Lamberts et al. CLINICAL CANCER RESEARCH
- RECIST 1.1—Update and clarification: From the RECIST committee
- (2016) Lawrence H. Schwartz et al. EUROPEAN JOURNAL OF CANCER
- The reoxygenation of hypoxia and the reduction of glucose metabolism in head and neck cancer by fractionated radiotherapy with intensity-modulated radiation therapy
- (2016) Shozo Okamoto et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- PI-RADS Prostate Imaging – Reporting and Data System: 2015, Version 2
- (2016) Jeffrey C. Weinreb et al. EUROPEAN UROLOGY
- Strategy of Using Intratreatment Hypoxia Imaging to Selectively and Safely Guide Radiation Dose De-escalation Concurrent With Chemotherapy for Locoregionally Advanced Human Papillomavirus–Related Oropharyngeal Carcinoma
- (2016) Nancy Lee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- An in silico approach helped to identify the best experimental design, population, and outcome for future randomized clinical trials
- (2016) Agathe Bajard et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Updating the American Society of Clinical Oncology Value Framework: Revisions and Reflections in Response to Comments Received
- (2016) Lowell E. Schnipper et al. JOURNAL OF CLINICAL ONCOLOGY
- Bridging the gaps in 18F PET tracer development
- (2016) Michael G. Campbell et al. Nature Chemistry
- Imaging biomarker roadmap for cancer studies
- (2016) James P. B. O'Connor et al. Nature Reviews Clinical Oncology
- Directions for new developments on statistical design and analysis of small population group trials
- (2016) Ralf-Dieter Hilgers et al. Orphanet Journal of Rare Diseases
- MR Imaging Radiomics Signatures for Predicting the Risk of Breast Cancer Recurrence as Given by Research Versions of MammaPrint, Oncotype DX, and PAM50 Gene Assays
- (2016) Hui Li et al. RADIOLOGY
- Critical parameters in targeted drug development: the pharmacological audit trail
- (2016) Udai Banerji et al. SEMINARS IN ONCOLOGY
- A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors
- (2016) Samit Chatterjee et al. Oncotarget
- High-Resolution PET Imaging with Therapeutic Antibody-based PD-1/PD-L1 Checkpoint Tracers
- (2016) Michael Hettich et al. Theranostics
- Molecular imaging as a tool to investigate heterogeneity of advanced HER2-positive breast cancer and to predict patient outcome under trastuzumab emtansine (T-DM1): the ZEPHIR trial
- (2015) G. Gebhart et al. ANNALS OF ONCOLOGY
- The value of PET/CT with FES or FDG tracers in metastatic breast cancer: a computer simulation study in ER-positive patients
- (2015) R G Koleva-Kolarova et al. BRITISH JOURNAL OF CANCER
- Radiopharmaceuticals as probes to characterize tumour tissue
- (2015) Israt S. Alam et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Antibody Positron Emission Tomography Imaging in Anticancer Drug Development
- (2015) Laetitia E. Lamberts et al. JOURNAL OF CLINICAL ONCOLOGY
- PET Imaging of Macrophage Mannose Receptor-Expressing Macrophages in Tumor Stroma Using 18F-Radiolabeled Camelid Single-Domain Antibody Fragments
- (2015) A. Blykers et al. JOURNAL OF NUCLEAR MEDICINE
- A risk management approach for imaging biomarker-driven clinical trials in oncology
- (2015) Yan Liu et al. LANCET ONCOLOGY
- Metrology Standards for Quantitative Imaging Biomarkers
- (2015) Daniel C. Sullivan et al. RADIOLOGY
- Serial [18F]-fluoromisonidazole PET during radiochemotherapy for locally advanced head and neck cancer and its correlation with outcome
- (2015) Nicole E. Wiedenmann et al. RADIOTHERAPY AND ONCOLOGY
- Academic–Industrial Collaboration: Toward the Consilience of Two Solitudes
- (2015) Stephen Hanessian ACS Medicinal Chemistry Letters
- Lapatinib access into normal brain and brain metastases in patients with Her-2 overexpressing breast cancer
- (2015) Azeem Saleem et al. EJNMMI Research
- 89Zr-trastuzumab and 89Zr-bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients
- (2014) S. B. M. Gaykema et al. CLINICAL CANCER RESEARCH
- Imaging Intratumor Heterogeneity: Role in Therapy Response, Resistance, and Clinical Outcome
- (2014) J. P. B. O'Connor et al. CLINICAL CANCER RESEARCH
- Tracking the Pharmaceutical Pipeline: Clinical Trials and Global Disease Burden
- (2014) Marci D. Cottingham et al. CTS-Clinical and Translational Science
- In vivo and in vitro evidence that 99mTc-HYNIC-interleukin-2 is able to detect T lymphocytes in vulnerable atherosclerotic plaques of the carotid artery
- (2014) Andor W. J. M. Glaudemans et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Modeling companion diagnostics in economic evaluations of targeted oncology therapies: systematic review and methodological checklist
- (2014) Brett Doble et al. EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
- (2014) Sally F. Barrington et al. JOURNAL OF CLINICAL ONCOLOGY
- 89Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment
- (2014) S. F. Oosting et al. JOURNAL OF NUCLEAR MEDICINE
- Systemic treatment for BRAF-mutant melanoma: where do we go next?
- (2014) Alexander M Menzies et al. LANCET ONCOLOGY
- Measuring Residual Estrogen Receptor Availability during Fulvestrant Therapy in Patients with Metastatic Breast Cancer
- (2014) Michel van Kruchten et al. Cancer Discovery
- Biomarker Discovery for Heterogeneous Diseases
- (2013) G. Wallstrom et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Multicenter trials using 18F-fluorodeoxyglucose (FDG) PET to predict chemotherapy response: Effects of differential measurement error and bias on power calculations for unselected and enrichment designs
- (2013) Brenda F Kurland et al. Clinical Trials
- High Reproducibility of Tumor Hypoxia Evaluated by 18F-Fluoromisonidazole PET for Head and Neck Cancer
- (2013) S. Okamoto et al. JOURNAL OF NUCLEAR MEDICINE
- 18F-Fluoromisonidazole PET Uptake Is Correlated with Hypoxia-Inducible Factor-1 Expression in Oral Squamous Cell Carcinoma
- (2013) J. Sato et al. JOURNAL OF NUCLEAR MEDICINE
- Multicenter Harmonization of 89Zr PET/CT Performance
- (2013) N. E. Makris et al. JOURNAL OF NUCLEAR MEDICINE
- Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer
- (2013) Alan L. Ho et al. NEW ENGLAND JOURNAL OF MEDICINE
- Exploratory geographical analysis of hypoxic subvolumes using 18F-MISO-PET imaging in patients with head and neck cancer in the course of primary chemoradiotherapy
- (2013) Martin-Immanuel Bittner et al. RADIOTHERAPY AND ONCOLOGY
- Potential of [18F]-Fluoromisonidazole positron-emission tomography for radiotherapy planning in head and neck squamous cell carcinomas
- (2013) B. Henriques de Figueiredo et al. STRAHLENTHERAPIE UND ONKOLOGIE
- Rapid Decrease in Delivery of Chemotherapy to Tumors after Anti-VEGF Therapy: Implications for Scheduling of Anti-Angiogenic Drugs
- (2012) Astrid A.M. Van der Veldt et al. CANCER CELL
- Nanobody-Based Targeting of the Macrophage Mannose Receptor for EffectiveIn VivoImaging of Tumor-Associated Macrophages
- (2012) Kiavash Movahedi et al. CANCER RESEARCH
- Outcomes of Phase II Clinical Trials with Single-Agent Therapies in Advanced/Metastatic Non-Small Cell Lung Cancer Published between 2000 and 2009
- (2012) F. Janku et al. CLINICAL CANCER RESEARCH
- The Renaissance of the 68Ge/68Ga Radionuclide Generator Initiates New Developments in 68Ga Radiopharmaceutical Chemistry
- (2012) Frank Roesch et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Radiomics: Extracting more information from medical images using advanced feature analysis
- (2012) Philippe Lambin et al. EUROPEAN JOURNAL OF CANCER
- Radiomics: the process and the challenges
- (2012) Virendra Kumar et al. MAGNETIC RESONANCE IMAGING
- Exploratory prospective trial of hypoxia-specific PET imaging during radiochemotherapy in patients with locally advanced head-and-neck cancer
- (2012) Daniel Zips et al. RADIOTHERAPY AND ONCOLOGY
- PET imaging with radiolabeled antibodies and tyrosine kinase inhibitors: immuno-PET and TKI-PET
- (2012) Guus A. M. S. van Dongen et al. TUMOR BIOLOGY
- 18F-fluoromisonidazole positron emission tomography before treatment is a predictor of radiotherapy outcome and survival prognosis in patients with head and neck squamous cell carcinoma
- (2011) Masahiro Kikuchi et al. ANNALS OF NUCLEAR MEDICINE
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Magnitude of Enhanced Permeability and Retention Effect in Tumors with Different Phenotypes: 89Zr-Albumin as a Model System
- (2011) C. Heneweer et al. JOURNAL OF NUCLEAR MEDICINE
- Erlotinib Accumulation in Brain Metastases from Non-small Cell Lung Cancer: Visualization by Positron Emission Tomography in a Patient Harboring a Mutation in the Epidermal Growth Factor Receptor
- (2011) Britta Weber et al. Journal of Thoracic Oncology
- Comparative biodistribution of imaging agents for in vivo molecular profiling of disseminated prostate cancer in mice bearing prostate cancer xenografts: focus on 111In- and 125I-labeled anti-HER2 humanized monoclonal trastuzumab and ABY-025 Affibody
- (2011) Jennie Malmberg et al. NUCLEAR MEDICINE AND BIOLOGY
- Reduction of [18F]Fluoromisonidazole Uptake After Neoadjuvant Chemotherapy for Head and Neck Squamous Cell Carcinoma
- (2010) Tomohiko Yamane et al. MOLECULAR IMAGING AND BIOLOGY
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- Prospective Trial Incorporating Pre-/Mid-Treatment [18F]-Misonidazole Positron Emission Tomography for Head-and-Neck Cancer Patients Undergoing Concurrent Chemoradiotherapy
- (2009) Nancy Lee et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Dose Painting in Radiotherapy for Head and Neck Squamous Cell Carcinoma: Value of Repeated Functional Imaging with 18F-FDG PET, 18F-Fluoromisonidazole PET, Diffusion-Weighted MRI, and Dynamic Contrast-Enhanced MRI
- (2009) P. Dirix et al. JOURNAL OF NUCLEAR MEDICINE
- On the Selection of a Tracer for PET Imaging of HER2-Expressing Tumors: Direct Comparison of a 124I-Labeled Affibody Molecule and Trastuzumab in a Murine Xenograft Model
- (2009) A. Orlova et al. JOURNAL OF NUCLEAR MEDICINE
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors
- (2009) R. L. Wahl et al. JOURNAL OF NUCLEAR MEDICINE
- Report on the First International Workshop on interim-PET scan in lymphoma
- (2009) Michel Meignan et al. LEUKEMIA & LYMPHOMA
- The National Oncologic PET Registry: Lessons Learned for Coverage With Evidence Development
- (2009) Sean Tunis et al. Journal of the American College of Radiology
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- Instructions to Authors∗
- (2008) INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Reproducibility of Intratumor Distribution of 18F-Fluoromisonidazole in Head and Neck Cancer
- (2008) Sadek A. Nehmeh et al. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
- Treatment With the Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate: Toxicity, Efficacy, and Survival
- (2008) Dik J. Kwekkeboom et al. JOURNAL OF CLINICAL ONCOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now